The official declaration of the end of the Democratic Republic of the Congo’s (DRC) two-year mpox emergency is a milestone in epidemiological management, yet it masks a fragile equilibrium between viral suppression and ongoing ecological reservoirs. Between 2022 and early 2026, the DRC recorded over 2,200 suspected deaths and tens of thousands of infections, primarily driven by the endemic Clade I variant. The termination of the outbreak status serves as a signal for resource reallocation, but the underlying mechanisms of viral transmission in the Congo Basin remain largely unaddressed. To evaluate the validity of this recovery, one must deconstruct the outbreak through three primary filters: the surveillance-to-reality gap, the zoonotic spillover threshold, and the geopolitical constraints of vaccine logistics.
The Surveillance-to-Reality Gap in Central African Epidemics
The reported figures—2,200 deaths and roughly 30,000 cases—are conservative estimates restricted by the logistical friction of a decentralized health system. The DRC’s surveillance infrastructure operates under a high "ascertainment bias," where severe cases and deaths in clinical settings are recorded, while mild or asymptomatic cases in remote provinces disappear from the dataset.
The primary bottleneck in data precision is the diagnostic deficit. While the World Health Organization (WHO) and regional partners have increased PCR testing capacity in Kinshasa and Goma, the rural "red zones" often rely on clinical diagnoses based on skin lesions. This creates a risk of false positives (misidentifying chickenpox or measles) and false negatives (missing early-stage mpox). The declaration of the outbreak's end assumes a specific transmission rate, $R_0 < 1$, maintained over a sustained period. However, $R_0$ is not a fixed biological constant; it is a function of population density, contact patterns, and the effectiveness of isolation protocols.
The Taxonomy of Clade I versus Clade II
Public perception of mpox shifted globally in 2022 due to the Clade IIb outbreak, which was characterized by lower mortality and high transmissibility via sexual networks in non-endemic regions. The DRC’s crisis was fundamentally different. The Clade I variant endemic to the Congo Basin has historically shown a case fatality rate (CFR) ranging from 1% to 10%, significantly higher than the < 1% observed in Clade IIb.
The structural severity of the DRC outbreak can be categorized into three distinct transmission tiers:
- Zoonotic Overflow: Initial infection from small mammals (rodents or non-human primates) to hunters or gatherers.
- Intra-household Clusters: Secondary transmission via direct contact with respiratory droplets or contaminated materials (fomites).
- Broadened Community Spread: The recent expansion into urban centers, where higher population turnover accelerated the virus's reach beyond its traditional ecological niche.
The transition from Tier 1 to Tier 3 in regions like North Kivu and Equateur indicates that the virus is no longer confined to remote forest communities. The declaration that the outbreak is "over" applies only to the surge in Tier 3 transmission; Tier 1 remains a permanent ecological reality.
Logistics and the "Cold Chain" Friction
The deployment of vaccines—specifically the JYNNEOS (MVA-BN) and LC16 vaccines—faced extreme operational hurdles. To understand why vaccination did not result in a faster resolution, one must analyze the "Cost-per-Dose Administered" (CPDA) in a conflict zone.
The financial cost of the vaccine itself is secondary to the logistical cost of the cold chain. Mpox vaccines require specific temperature controls (typically -20°C to 8°C depending on the duration of storage). In provinces where the power grid is non-existent, the reliance on solar-powered refrigerators and manual transport into the interior creates a high "attrition rate" for vaccine potency. Furthermore, the two-dose regimen required for maximum efficacy is difficult to execute in displaced populations. If 40% of the first-dose recipients are lost to follow-up due to internal migration or conflict, the herd immunity threshold remains unreachable.
The Conflict-Disease Nexus
Eastern DRC remains a theater of active conflict between the M23 rebels and government-aligned forces. This instability creates a "Disease Reservoir Paradox." In conflict zones, formal health reporting ceases, creating a blind spot for epidemiologists. When people flee violence, they move into overcrowded camps with poor sanitation, which acts as an accelerant for transmission.
The cessation of the outbreak was achieved not through a total eradication of the virus, but through a saturation of the initial high-risk pools and a massive, albeit delayed, surge in international aid. The risk is that the withdrawal of emergency funding will occur before the "silent transmission" in the East is neutralized.
Quantitative Analysis of the Mortality Rate
The 2,200 deaths represent a crude mortality metric. When adjusted for the high proportion of children infected—historically over 60% of cases in the DRC—the data reveals a severe vulnerability in pediatric immunology. Children in the DRC often suffer from comorbidities such as malnutrition or malaria, which lower the threshold for viral complications.
We can model the impact using a simplified severity function:
$$S = \frac{V \cdot (1 - I)}{N + C}$$
Where $S$ is systemic risk, $V$ is viral virulence (Clade I), $I$ is population immunity, $N$ is nutritional status, and $C$ is access to clinical care. In the DRC, as $N$ and $C$ decrease, $S$ increases exponentially regardless of $V$.
Structural Limitations of the "Outbreak Over" Label
International health regulations (IHR) require specific criteria for declaring an end to a Public Health Emergency of International Concern (PHEIC). While the DRC has seen a sufficient decline in weekly case counts to meet these criteria, the "End of Outbreak" status is often a political and economic decision as much as a clinical one.
The label allows for:
- Economic Reintegration: Removal of travel advisories and restoration of trade flows.
- Resource Reallocation: Shifting funds from mpox to other endemic crises like measles or cholera.
- Surveillance Fatigue: A psychological easing that often leads to a drop in community vigilance.
The second limitation is the "Animal Reservoir" factor. Unlike smallpox, which had no animal host and could be eradicated, mpox is zoonotic. The virus will continue to circulate in the squirrel and rodent populations of the Congo Basin. Therefore, "ending" an outbreak is a temporary suppression of a spillover event, not the removal of the threat.
Strategic Transition to Endemic Management
The move from an emergency response to a routine health program requires a fundamental shift in strategy. The focus must transition from reactive mass vaccination to a targeted, high-precision surveillance model.
- Sentinel Site Enhancement: Establishing permanent diagnostic hubs in key border towns and forest-edge communities to detect Tier 1 spillover events within 48 hours.
- Genomic Surveillance: Continuous sequencing of viral samples to detect mutations that might increase transmissibility or provide resistance to current antivirals like Tecovirimat (TPOXX).
- Behavioral Economics in Public Health: Developing communication strategies that address "vaccine hesitancy" and "bushmeat consumption" without alienating local populations or disrupting protein sources.
The long-term threat is not a return to the 2022-2024 surge, but the potential for Clade I to adapt for more efficient human-to-human transmission. If the global health community treats this declaration as a "mission accomplished" moment, it ignores the reality that the DRC is an evolutionary laboratory for orthopoxviruses.
Continued investment in the African Centers for Disease Control (Africa CDC) and local manufacturing of diagnostic tests is the only path to breaking the cycle of panic and neglect. The true measure of success will not be the absence of cases in 2026, but the speed of containment when the next spillover inevitably occurs. National health ministries should now prioritize the integration of mpox screening into existing maternal and child health programs, ensuring that the infrastructure built during the emergency becomes a permanent fixture of the DRC’s primary care system.
